April 2012
American Journal of Health-System Pharmacy;4/1/2012, Vol. 69 Issue 7, p533
Academic Journal
The article offers brief information on the topics discussed in the articles within the issue. Flow rate of an elastomeric infusion pump was unaffected by atmospheric pressure conditions until its reservoir and flow-restrictor housing were under same conditions. Available literature does not support medical society's guideline suggesting safety and efficacy of Glucagon. Management of outlander syndrome in pharmacists routinely working in a physical space outside the pharmacy department.


Related Articles

  • Safety and efficacy of glucagon for the relief of acute esophageal food impaction. WEANT, KYLE A.; WEANT, MALLIKA P. // American Journal of Health-System Pharmacy;4/1/2012, Vol. 69 Issue 7, p573 

    Purpose. The safety and efficacy of i.v. glucagon for the relief of acute esophageal food impaction were evaluated. Summary. The medical literature was reviewed to identify published trials and case series on the use of i.v. glucagon for the relief of acute esophageal food impaction. Individual...

  • Methotrexate-associated B-cell lymphoma presenting with acute renal failure and bilateral nephromegaly. Nasr, S. H.; Alobeid, B.; Jacobs, J. M.; Peacock, T. E.; D'Agati, V. D.; Markowitz, G. S. // Kidney International;Feb2007, Vol. 71 Issue 3, p272 

    A 73-year-old female patient with a history of systemic lupus erythematosus for 10 years presented with acute renal failure and a creatinine of 2.9mg/dl (256 μmol/l). The patient had a baseline creatinine of 1.0mg/dl (88 μmol/l) 3 months prior. Past medical history included sicca syndrome,...

  • Methotrexate.  // Reactions Weekly;9/18/2004, Issue 1019, p11 

    Discusses research being done on the side effect of methotrexate leading to the death of an elderly patient with end-stage renal failure. Reference to a study by J. A. Chess and colleagues published in the August 2004 issue of "Nephrology Dialysis Transplantation"; Development of neutropenia...

  • Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Karie, S.; Gandjbakhch, F.; Janus, N.; Launay-Vacher, V.; Rozenberg, S.; Ba, C. U. Mai; Bourgeois, P.; Deray, G. // Rheumatology;Mar2008, Vol. 47 Issue 3, p350 

    Objectives. The prevalence of kidney disease (KD) indicators together with the profile of RA drugs prescribed in RA patients was investigated in the MATRIX study (MeThotreXate And Renal Insufficiency).

  • Dose and cost comparison of erythropoietic agents in the inpatient hospital setting. Vekeman, Francis; McKenzie, R. Scott; Lefebvre, Patrick; Watson, Sue H.; Mody, Samir H.; Tak Piech, Catherine; Mei Sheng Duh // American Journal of Health-System Pharmacy;9/15/2007, Vol. 64 Issue 18, p1943 

    Purpose. The inpatient dosing patterns and treatment costs in cancer and predialysis chronic kidney disease (CKD) patients treated with erythropoietic agents from a hospital pharmacy perspective were studied. Methods. An analysis of electronic inpatient records from the Premier Perspective...

  • Elevated level of serum cystatin-C concentration is a useful predictor for myelosuppression induced by methotrexate for treatment of rheumatoid arthritis. Hayashi, Taichi; Ito, Satoshi; Goto, Daisuke; Matsumoto, Isao; Sumida, Takayuki // Modern Rheumatology (Springer Science & Business Media B.V.);Dec2010, Vol. 20 Issue 6, p548 

    Methotrexate (MTX) is indispensable for the treatment of rheumatoid arthritis (RA). However, a small number of patients treated with MTX occasionally encounter some life-threatening events, including myelosuppression. Renal insufficiency, one of risk factors for these events, is difficult to...

  • New portable infusion pump for prolonged subcutaneous administration of opioid analgesics in patients with advanced cancer.  // British Medical Journal (Clinical Research Edition);6/7/1986, Vol. 292 Issue 6534, p1496 

    Examines the durability of Act-a-Pump infusion pump in Great Britain. Use of pump for opioid analgesic administrator; Advantages of Act-a-Pack; Features of the infusion pumps.

  • Immunoglobulin Replacement Therapy by Slow Subcutaneous Infusion. Berger, Melvin; Cupps, Thomas R.; Fauci, Anthony S. // Annals of Internal Medicine;Jul80 Part 1, Vol. 93 Issue 1, p55 

    Reports the successful use of a small portable pump to administer increased amounts of immune serum globulin by slow subcutaneous infusion. Description of the infusion pumps; Background on the patients; Benefit of the infusion technique.

  • Rigel Medical introduces infusion pump testing in new free booklet.  // Operating Theatre Journal;Sep2014, Issue 288, p4 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics